Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators

Details for Australian Patent Application No. 2007288253 (hide)

Owner VALEANT PHARMACEUTICALS INTERNATIONAL

Inventors Vernier, Jean-Michel; Cheney, Ian Wayne; Wu, Jim Zhen; De La Rosa, Martha Alicia; Chen, Huanming; Larson, Gary Lee

Agent Griffith Hack

Pub. Number AU-A-2007288253

PCT Pub. Number WO2008/024398

Priority 60/839,941 23.08.06 US

Filing date 22 August 2007

Wipo publication date 28 February 2008

International Classifications

A61K 31/47 (2006.01) - Quinolines

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/024398 Priority application(s): WO2008/024398

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007288256-Intermittent high-energy cardiac stimulation for therapeutic effect

2007288245-2- (pyrazin-2-yl) -thiazole and 2- (1h-pyrazol-3-yl) -thiazole derivatives as well as related compounds as stearoyl-CoA desaturase (SCD) inhibitors for the treatment of metabolic, cardiovascular and other disorders